Zobrazeno 1 - 10
of 194
pro vyhledávání: '"S. Capobianco"'
Autor:
A. Elia, M. Pickering, M. Girardello, G. Oton, G. Ceccherini, S. Capobianco, M. Piccardo, G. Forzieri, M. Migliavacca, A. Cescatti
Publikováno v:
The International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences, Vol XLVIII-4-W7-2023, Pp 41-46 (2023)
The increasing availability of remotely sensed data have offered unprecedented possibilities for monitoring and analysis of environmental variables, including boosting recent studies in the field of ecosystem resilience relying on indicators derived
Externí odkaz:
https://doaj.org/article/b49a0c5c2ba441dcb2e399a4b6f136d4
Autor:
Luisina M. Solernó, Natasha T. Sobol, María F. Gottardo, Carla S. Capobianco, Maximiliano R. Ferrero, Liliana Vásquez, Daniel F. Alonso, Juan Garona
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-18 (2022)
Abstract Osteosarcoma is still associated with limited response to standard-of-care therapy and alarmingly elevated mortality rates, especially in low- and middle-income countries. Despite multiple efforts to repurpose β-blocker propranolol in oncol
Externí odkaz:
https://doaj.org/article/76e6670f3c4042928bf7821dcad04983
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Johanna E. Sidabra, Silvio E. Perea, Hernan G. Farina, Carla S. Capobianco, Maria F. Gottardo, Yasser Perera, Daniel F. Alonso, Juan Garona
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
CK2 is a serine/threonine kinase that is overexpressed in breast cancer and its inhibition is associated to reduced tumor growth and disease progression. CIGB-300 is an antitumor peptide with a novel mechanism of action, since it binds to protein kin
Autor:
Luisina M, Solernó, Natasha T, Sobol, María F, Gottardo, Carla S, Capobianco, Maximiliano R, Ferrero, Liliana, Vásquez, Daniel F, Alonso, Juan, Garona
Publikováno v:
Scientific reports. 12(1)
Osteosarcoma is still associated with limited response to standard-of-care therapy and alarmingly elevated mortality rates, especially in low- and middle-income countries. Despite multiple efforts to repurpose β-blocker propranolol in oncology, its
Autor:
Liliana Vasquez, Carla S. Capobianco, Luisina M. Solernó, Giselle V. Ripoll, Juan Garona, Daniel Fernando Alonso, Natasha Tatiana Sobol
Background: Osteosarcoma is still associated with poor response to therapy and alarmingly elevated mortality rates, especially in developing countries, highlighting the urgent need of novel therapeutic strategies. Given that β-adrenergic receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75cbaaab23248d5435ce8695a5f62f8c
https://doi.org/10.21203/rs.3.rs-44912/v1
https://doi.org/10.21203/rs.3.rs-44912/v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gretel M. Ferreira, Mariano R. Gabri, Selene Rojo, Valeria Inés Segatori, Héctor Adrián Cuello, Daniel A. Alonso, Cynthia A. Gulino, Carla S. Capobianco
Publikováno v:
Cancer Research. 80:6648-6648
N-glycolylneuraminic acid (NeuGc) is a sialic acid molecule present in mammalian cells as terminal constituents of membrane glycoconjugates such as gangliosides and glycoproteins. Although the role of NeuGc-containing glycoconjugates in human cancer
Autor:
Hernan G. Farina, Carla S. Capobianco, María Florencia Gottardo, Daniel F. Alonso, Johanna E. Sidabra
Publikováno v:
Cancer Research. 80:2649-2649
Breast cancer is the first cause of death from female cancer. After treatments against the primary tumor, a few cells can prevail in a dormant state for a long period, becoming minimal residual disease. These cells can resume growth and establish as
Autor:
Johanna E. Sidabra, Carla S. Capobianco, Maria F. Gottardo, Juan Garona, Daniel F. Aonso, Silvio Perea Rodriguez, Hernan G. Farina
Publikováno v:
Cancer Research. 80:6232-6232
CK2 is a serine/threonine kinase that is overexpressed in breast cancer and its inhibition is associated to reduced tumor growth and disease progression. With more than three hundred substrates, this kinase is involved in a large number of cellular f